MiMedx Group, Inc. Announces 2024 Annual Meeting of Shareholders

TL;DR

<b>MiMedx Group, Inc. will hold its 2024 virtual annual meeting on June 5, 2024, with key proposals including director elections and executive compensation approval.</b>

AI Summary

MIMEDX GROUP, INC. (MDXG) filed a Proxy Statement (DEF 14A) with the SEC on April 23, 2024. The 2024 annual meeting of shareholders for MiMedx Group, Inc. will be held via live webcast on June 5, 2024, at 9:00 a.m. ET. Shareholders must pre-register by 5:00 p.m. ET on June 4, 2024, to attend the virtual meeting. The meeting agenda includes the election of nine directors, an advisory vote on executive compensation, and ratification of Deloitte & Touche LLP as the independent auditor for fiscal year 2024. The record date for determining eligible shareholders is April 8, 2024, at 5:00 p.m. ET. The Board of Directors unanimously recommends voting for the election of nominees and other proposals.

Why It Matters

For investors and stakeholders tracking MIMEDX GROUP, INC., this filing contains several important signals. Shareholders need to be aware of the virtual format and registration deadlines to participate in the annual meeting and exercise their voting rights. The ratification of Deloitte & Touche LLP is a standard procedural item, but its approval by shareholders is crucial for the company's financial reporting integrity.

Risk Assessment

Risk Level: low — MIMEDX GROUP, INC. shows low risk based on this filing. The filing is a routine proxy statement for an annual shareholder meeting, containing standard proposals and no immediate material changes or significant risks.

Analyst Insight

Shareholders should review the proxy materials to make informed voting decisions on director nominees, executive compensation, and auditor ratification.

Key Numbers

• 9 — Directors (Number of directors to be elected at the Annual Meeting.)
• 2024 — Fiscal Year (Fiscal year ending December 31, 2024, for which the independent auditor is being ratified.)
• 2024 — Annual Meeting Year (Year of the annual shareholder meeting.)

Key Players & Entities

• MIMEDX GROUP, INC. (company) — Filer and registrant
• Deloitte & Touche LLP (company) — Proposed independent registered public accounting firm
• June 5, 2024 (date) — Date of the Annual Meeting
• April 8, 2024 (date) — Record date for shareholder eligibility
• April 23, 2024 (date) — Filing date of the proxy statement
• 9:00 a.m. Eastern Time (time) — Start time of the Annual Meeting
• www.virtualshareholdermeeting.com/MDXG2024 (url) — Link to attend the virtual meeting
• www.proxyvote.com (url) — Link for shareholder pre-registration

FAQ

Risk Factors

• Compliance with SEC Regulations [low — regulatory]: The company must comply with all SEC rules and regulations regarding proxy solicitations and annual meetings.
• Independent Auditor Ratification [low — financial]: Shareholders will vote on ratifying Deloitte & Touche LLP as the independent auditor for fiscal year 2024, impacting financial reporting.
• Virtual Meeting Format [low — operational]: The annual meeting will be held virtually, requiring shareholders to register and access the webcast online.

Key Dates

• 2024-06-05: Annual Meeting of Shareholders — Shareholders will vote on key proposals including director elections and executive compensation.
• 2024-06-04T17:00:00.000Z: Shareholder Pre-registration Deadline — Deadline for shareholders to pre-register to attend the virtual meeting.

Key Financial Figures

• $0.001 — f the Company's common stock, par value $0.001 per share (" Company common stock ") on

Filing Documents

• ny20024697x1_def14a.htm (DEF 14A) — 1117KB
• ny20024697x1_leadership.jpg (GRAPHIC) — 150KB
• logo_mimedx.jpg (GRAPHIC) — 36KB
• ny20024697x1_diagram01.jpg (GRAPHIC) — 284KB
• ny20024697x1_barchart01.jpg (GRAPHIC) — 78KB
• ny20024697x1_pc01.jpg (GRAPHIC) — 638KB
• ny20024697x1_pc02.jpg (GRAPHIC) — 609KB
• 0001140361-24-021104.txt (&nbsp;) — 6375KB
• mdxg-20240605.xsd (EX-101.SCH) — 4KB
• mdxg-20240605_def.xml (EX-101.DEF) — 4KB
• mdxg-20240605_lab.xml (EX-101.LAB) — 6KB
• mdxg-20240605_pre.xml (EX-101.PRE) — 8KB
• ny20024697x1_def14a_htm.xml (XML) — 102KB

EXECUTIVE COMPENSATION

EXECUTIVE COMPENSATION 22 Compensation Discussion and Analysis 22 Compensation Committee Report 36 Summary Compensation Table (2023, 2022 and 2021) 37 Grants of Plan-Based Awards for 2023 38 Outstanding Equity Awards as of December 31, 2023 39 2023 Option Exercises and Stock Vested Table 40 2023 Potential Payments Upon Termination or Change in Control 41 PROPOSAL 2—ADVISORY APPROVAL OF EXECUTIVE COMPENSATION 44 DIRECTOR COMPENSATION 46 CEO PAY RATIO 46 PAY VERSUS PERFORMANCE 47 EQUITY COMPENSATION PLAN INFORMATION 49 AUDIT MATTERS 50 Independent Auditor Fees and Services 50 REPORT OF THE AUDIT COMMITTEE 51 PROPOSAL 3—RATIFICATION OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM 52

SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT

SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT 53 OTHER MATTERS 55 Proxy Solicitation Costs 55 Shareholders Proposals and Director Nominations for the 2025 Annual Meeting of Shareholders 55 Householding of Proxy Materials 56 Additional Information 56 APPENDIX A – RECONCILLIATION OF NON-GAAP MEASURES A-1 TABLE OF CONTENTS PROXY STATEMENT FOR THE 2024 ANNUAL MEETING OF SHAREHOLDERS TO BE HELD ON JUNE 5, 2024 This proxy statement (including all appendices attached hereto, this " Proxy Statement ") is furnished in connection with the solicitation of proxies by the Board of Directors (the " Board ") of MiMedx Group, Inc. (" MiMedx, " the " Company, " " we " or " us ") to be voted at the 2024 annual meeting of shareholders (including any adjournment or postponement thereof, the " Annual Meeting " or the " 2024 Annual Meeting ") of the Company to be held in virtual format only on June 5, 2024 , at 9:00 a.m. Eastern time at www.virtualshareholdermeeting.com/MDXG2024. The Notice of Annual Meeting of Shareholders, this Proxy Statement (including a proxy card or voting instruction form, as applicable) and our Annual Report on Form 10-K for the fiscal year ended December 31, 2023 (the " 2023 Annual Report ") are being first sent or given to our shareholders on or about April 22, 2024. The Company, on behalf of our board of directors (the " Board "), is soliciting your proxy to vote your shares at the Annual Meeting in accordance with your instructions. The Notice of Annual Meeting of Shareholders, this Proxy Statement, the 2023 Annual Report, and our form of proxy card are available at www.proxyvote.com. Our principal executive offices are located at 1775 West Oak Commons Court, NE, Marietta, Georgia, 30062. INFORMATION ABOUT THE ANNUAL MEETING 1. What is a proxy? A proxy is your legal designation of another person to vote the shares of MiMedx you own on your behalf. 2. Who is soliciting my proxy? The Board is soliciting your p

View Full Filing

View this DEF 14A filing on SEC EDGAR